Boston Scientific Corp (BSX)
91.50
+1.33
(+1.48%)
USD |
NYSE |
Nov 21, 16:00
91.40
-0.10
(-0.11%)
Pre-Market: 05:22
Boston Scientific Shareholders Equity (Quarterly): 20.71B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 20.71B |
June 30, 2024 | 20.37B |
March 31, 2024 | 19.92B |
December 31, 2023 | 19.28B |
September 30, 2023 | 18.88B |
June 30, 2023 | 18.23B |
March 31, 2023 | 17.85B |
December 31, 2022 | 17.57B |
September 30, 2022 | 17.64B |
June 30, 2022 | 17.25B |
March 31, 2022 | 16.74B |
December 31, 2021 | 16.62B |
September 30, 2021 | 16.46B |
June 30, 2021 | 15.94B |
March 31, 2021 | 15.72B |
December 31, 2020 | 15.33B |
September 30, 2020 | 15.56B |
June 30, 2020 | 15.62B |
March 31, 2020 | 13.80B |
December 31, 2019 | 13.88B |
September 30, 2019 | 9.698B |
June 30, 2019 | 9.424B |
March 31, 2019 | 9.232B |
December 31, 2018 | 8.725B |
September 30, 2018 | 8.289B |
Date | Value |
---|---|
June 30, 2018 | 7.744B |
March 31, 2018 | 7.029B |
December 31, 2017 | 7.011B |
September 30, 2017 | 7.588B |
June 30, 2017 | 7.235B |
March 31, 2017 | 7.053B |
December 31, 2016 | 6.733B |
September 30, 2016 | 6.482B |
June 30, 2016 | 6.22B |
March 31, 2016 | 6.457B |
December 31, 2015 | 6.32B |
September 30, 2015 | 6.41B |
June 30, 2015 | 6.58B |
March 31, 2015 | 6.501B |
December 31, 2014 | 6.457B |
September 30, 2014 | 6.701B |
June 30, 2014 | 6.544B |
March 31, 2014 | 6.534B |
December 31, 2013 | 6.539B |
September 30, 2013 | 6.563B |
June 30, 2013 | 6.603B |
March 31, 2013 | 6.503B |
December 31, 2012 | 6.87B |
September 30, 2012 | 6.828B |
June 30, 2012 | 7.728B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
13.80B
Minimum
Mar 2020
20.71B
Maximum
Sep 2024
17.17B
Average
16.99B
Median
Shareholders Equity (Quarterly) Benchmarks
Baxter International Inc | 7.872B |
Haemonetics Corp | 878.85M |
ResMed Inc | 5.195B |
Globus Medical Inc | 4.069B |
Abbott Laboratories | 39.80B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 38.08B |
Total Liabilities (Quarterly) | 17.12B |
Debt to Equity Ratio | 0.5254 |
Current Ratio | 1.482 |
Net Debt Paydown Yield | -0.30% |